Showing results (1671-1680 of 2,023) with videos related to
Sort By:
Pageof 203
Scientific Reports|July 20, 2025
Morpho-cultural and molecular characterization of trichoderma species from the northwestern himalayan apple rhizosphere of IndiaSana Surma, Sumaira H, Misbah M, et al.Journal of Medical Internet Research|May 23, 2024
Findings From a National Survey of Older US Adults on Patient Willingness to Use Telehealth Services: Cross-Sectional SurveyOlufeyisayo O Odebunmi, Tamera D Hughes, Austin R Waters, et al.Canadian Journal of Surgery. Journal Canadien De Chirurgie|July 22, 2010
Occult pneumothoraces in patients with penetrating trauma: Does mechanism matter?Chad G Ball, Christopher J Dente, Andrew W Kirkpatrick, et al.Open Forum Infectious Diseases|September 30, 2020
Cardiovascular Disease Risk Management in Persons With HIV: Does Clinician Specialty Matter?Nwora Lance Okeke, Katherine R Schafer, Eric G Meissner, et al.Hepatology (Baltimore, Md.)|October 17, 2018
Colder Weather and Fewer Sunlight Hours Increase Alcohol Consumption and Alcoholic Cirrhosis WorldwideMeritxell Ventura-Cots, Ariel E Watts, Monica Cruz-Lemini, et al.Cancer Genetics|April 27, 2024
Clinical management of TP53 mosaic variants found on germline genetic testingAbigail Ward, Dana Farengo-Clark, Danielle B McKenna, et al.Journal of the American College of Radiology : JACR|November 19, 2021
ACR Appropriateness Criteria® Diffuse Lung Disease, Stephen B Hobbs, Jonathan H Chung, et al.European Journal of Heart Failure|December 24, 2016
Prognostic burden of heart failure recorded in primary care, acute hospital admissions, or both: a population-based linked electronic health record cohort study in 2.1 million peopleStefan Koudstaal, Mar Pujades-Rodriguez, Spiros Denaxas, et al.Traffic (Copenhagen, Denmark)|June 16, 2010
Zebrafish class 1 phosphatidylinositol transfer proteins: PITPbeta and double cone cell outer segment integrity in retinaKristina E Ile, Sean Kassen, Canhong Cao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2019
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid LeukemiaKendra Sweet, Rami Komrokji, Eric Padron, et al.Pageof 203